These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Activity of cefuroxime against bacterial strains isolated from acute otitis media]. Simonet M, Herrmann JL, Veron M. Pathol Biol (Paris); 1990 May; 38(5):355-7. PubMed ID: 2367151 [Abstract] [Full Text] [Related]
6. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy. Turik MA, Johns D. J Chemother; 1998 Aug; 10(4):306-12. PubMed ID: 9720470 [Abstract] [Full Text] [Related]
7. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Perry CM, Scott LJ. Drugs; 2004 Aug; 64(13):1433-64. PubMed ID: 15212560 [Abstract] [Full Text] [Related]
8. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis. Doern GV. Diagn Microbiol Infect Dis; 1991 Aug; 14(1):75-7. PubMed ID: 1901536 [Abstract] [Full Text] [Related]
12. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin. Williams KJ, Hebblethwaite EM, Brown GW, Cox DM, Plested SJ. Drugs Exp Clin Res; 1987 Aug; 13(2):95-9. PubMed ID: 3556123 [Abstract] [Full Text] [Related]
13. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Dagan R, Abramson O, Leibovitz E, Lang R, Goshen S, Greenberg D, Yagupsky P, Leiberman A, Fliss DM. Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545 [Abstract] [Full Text] [Related]
15. Treatment of otitis media with cefuroxime axetil. Aronovitz GH. South Med J; 1988 Aug; 81(8):978-80. PubMed ID: 3043692 [Abstract] [Full Text] [Related]
16. Oral cefuroxime axetil compared with oral ampicillin in treating acute uncomplicated gonorrhoea. Wanas TM, Williams PE. Genitourin Med; 1986 Aug; 62(4):221-3. PubMed ID: 3733084 [Abstract] [Full Text] [Related]
17. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production. Blandino G, Aleo G, Caccamo F, Nicolosi VM, Siracusa V, Speciale A. J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715 [Abstract] [Full Text] [Related]
18. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections. Hebblethwaite EM, Brown GW, Cox DM. Drugs Exp Clin Res; 1987 Jun; 13(2):91-4. PubMed ID: 3582135 [Abstract] [Full Text] [Related]